Vimarsana
Biggest News Aggregation in the World

Page 2 - Double Blinded News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Double Blinded. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Double Blinded Today - Breaking & Trending Today

Organicell Regenerative Medicine: Organicell And Proxima CRO Set To Open Clinical Trial For Long Hauler COVID-19 Patients - Vimarsana News

Organicell Regenerative Medicine: Organicell And Proxima CRO Set To Open Clinical Trial For Long Hauler COVID-19 Patients

MIAMI, FL / ACCESSWIRE / February 8, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced

Organicell Regenerative Medicine : And Proxima CRO Set To Open Clinical Trial For Long Hauler COVID-19 Patients - Form 8-K - Vimarsana News

Organicell Regenerative Medicine : And Proxima CRO Set To Open Clinical Trial For Long Hauler COVID-19 Patients - Form 8-K

Organicell And Proxima CRO Set To Open Clinical Trial For Long Hauler COVID-19 Patients PRESS RELEASE Miami, FL Miami -Organicell Regenerative Medicine, Inc. , a... | February 8, 2022

Organicell Regenerative Medicine, Inc. Provides Updates of Clinical Trial Activities - Vimarsana News

Organicell Regenerative Medicine, Inc. Provides Updates of Clinical Trial Activities

MIAMI, FL / ACCESSWIRE / December 29, 2021 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, is pleased

Sorrento Announces Encouraging Results From Two Phase 2 - Vimarsana News

Sorrento Announces Encouraging Results From Two Phase 2

Abivertinib is an oral capsule (100 mg QD or two 50-mg capsules a day) that potentially reduces cytokine storm associated with acute respiratory distress...

Sorrento Announces Encouraging Results From Two Phase 2 Studies of Abivertinib For Treatment Of ... - Vimarsana News

Sorrento Announces Encouraging Results From Two Phase 2 Studies of Abivertinib For Treatment Of ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com